Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:HIMSNYSE:SMR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHIMSHims & Hers Health$46.37+12.0%$49.65$13.47▼$72.98$9.27B2.0922.86 million shs64.15 million shsSMRNuScale Power$38.29-1.0%$27.46$6.88▼$45.31$10.99B29.79 million shs9.81 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHIMSHims & Hers Health+12.00%-24.10%-13.15%+59.31%+115.06%SMRNuScale Power-1.07%-2.21%+7.39%+156.24%+232.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHIMSHims & Hers Health2.3306 of 5 stars2.03.00.00.01.73.31.9SMRNuScale Power1.6948 of 5 stars2.32.00.00.03.12.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHIMSHims & Hers Health 1.93Reduce$38.31-17.38% DownsideSMRNuScale Power 2.43Hold$31.57-17.54% DownsideCurrent Analyst Ratings BreakdownLatest SMR and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025SMRNuScale PowerBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral6/24/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$45.006/23/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell6/23/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$30.006/23/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform ➝ Underperform6/23/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold6/23/2025SMRNuScale PowerCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$46.006/11/2025HIMSHims & Hers HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$40.006/4/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$61.00 ➝ $65.005/29/2025SMRNuScale PowerCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$26.00 ➝ $35.005/29/2025SMRNuScale PowerUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$17.00 ➝ $34.00(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHIMSHims & Hers Health$1.48B7.03$0.39 per share117.59$2.16 per share21.47SMRNuScale Power$37.04M293.95$0.15 per share258.83$1.64 per share23.34Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHIMSHims & Hers Health$126.04M$0.6967.2089.171.569.24%22.75%15.51%8/4/2025 (Estimated)SMRNuScale Power-$136.62M-$1.37N/AN/AN/A-273.36%0.09%0.07%8/6/2025 (Estimated)Latest SMR and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025SMRNuScale Power-$0.1694-$0.11+$0.0594-$0.11$1.46 million$13.38 million5/5/2025Q1 2025HIMSHims & Hers Health$0.12$0.20+$0.08$0.20$535.21 million$586.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHIMSHims & Hers HealthN/AN/AN/AN/AN/ASMRNuScale PowerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHIMSHims & Hers HealthN/A1.591.32SMRNuScale PowerN/A6.236.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHIMSHims & Hers Health63.52%SMRNuScale Power78.37%Insider OwnershipCompanyInsider OwnershipHIMSHims & Hers Health13.71%SMRNuScale Power1.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHIMSHims & Hers Health1,637223.83 million193.15 millionOptionableSMRNuScale Power440284.39 million280.78 millionOptionableSMR and HIMS HeadlinesRecent News About These CompaniesNuScale Power Corporation (SMR) - Yahoo Finance5 hours ago | finance.yahoo.comCiti Starts Coverage of NuScale Power (SMR) Stock, Gives NeutralJune 26 at 4:07 PM | msn.comNuScale (SMR) Drops by Double Digits on Analyst DowngradeJune 26 at 4:07 PM | finance.yahoo.comNuScale Power (NYSE:SMR) Shares Down 1.2% - Here's What HappenedJune 26 at 2:41 PM | marketbeat.comBTIG Downgrades NuScale Power (SMR)June 26 at 11:06 AM | msn.comKG&L Capital Management LLC Invests $365,000 in NuScale Power Corporation (NYSE:SMR)June 26 at 7:29 AM | marketbeat.comWealth Effects LLC Takes $683,000 Position in NuScale Power Corporation (NYSE:SMR)June 26 at 6:13 AM | marketbeat.comLegacy Advisors LLC Acquires Shares of 13,140 NuScale Power Corporation (NYSE:SMR)June 26 at 4:32 AM | marketbeat.comNuScale Power (NYSE:SMR) Stock Rating Lowered by BTIG ResearchJune 26 at 2:43 AM | americanbankingnews.comSMR simulator to prepare future nuclear engineersJune 25 at 1:37 PM | insights.globalspec.comINuScale Power (NYSE:SMR) Stock Price Down 8.5% - Here's What HappenedJune 25 at 1:29 PM | marketbeat.comNuScale Power vs. Centrus Energy: Which Nuclear Stock Has an Edge Now?June 25 at 12:35 PM | zacks.comNuScale Power (NYSE:SMR) Shares Gap Down - Here's What HappenedJune 25 at 11:05 AM | marketbeat.comBTIG downgrades NuScale to “neutral,” cites valuation and orderbook uncertaintyJune 25 at 8:35 AM | investing.comNuScale Power (SMR) Skyrockets 18.47% on Paragon Energy PartnershipJune 25 at 8:35 AM | msn.comNuScale Power (NYSE:SMR) Rating Lowered to "Neutral" at BTIG ResearchJune 25 at 8:22 AM | marketbeat.comHere Are My Top 5 Energy Stocks to Buy NowJune 25 at 4:15 AM | fool.comParagon Enters Strategic Agreement with NuScale Power for Monitoring and Protection TechnologiesJune 24 at 5:35 PM | kxan.comKNuScale Power (NYSE:SMR) Trading Up 10.1% - Should You Buy?June 24 at 1:46 PM | marketbeat.comNuScale Power (NYSE:SMR) Shares Gap Up - Here's What HappenedJune 24 at 11:58 AM | marketbeat.comCitigroup Initiates Coverage of NuScale Power (SMR) with Neutral RecommendationJune 24 at 5:57 AM | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeHims & Hers Stock: Buy the Dip or Wait It Out?By Gabriel Osorio-Mazilli | June 5, 2025View Hims & Hers Stock: Buy the Dip or Wait It Out?Why Hims & Hers Stock Could Be a Multi-Bagger in the MakingBy Gabriel Osorio-Mazilli | June 24, 2025View Why Hims & Hers Stock Could Be a Multi-Bagger in the Making5 Stocks Set to Soar This SummerBy Ryan Hasson | June 2, 2025View 5 Stocks Set to Soar This Summer3 High-Growth Stocks Traders Love and Investors Should WatchBy Chris Markoch | June 5, 2025View 3 High-Growth Stocks Traders Love and Investors Should WatchSMR and HIMS Company DescriptionsHims & Hers Health NYSE:HIMS$46.37 +4.96 (+11.97%) Closing price 06/26/2025 03:59 PM EasternExtended Trading$46.30 -0.06 (-0.14%) As of 06/26/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.NuScale Power NYSE:SMR$38.28 -0.38 (-0.97%) Closing price 06/26/2025 03:59 PM EasternExtended Trading$38.46 +0.18 (+0.46%) As of 06/26/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs. The company was founded in 2007 and is headquartered in Portland, Oregon. NuScale Power Corporation operates as a subsidiary of Fluor Enterprises, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
